These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Natural history of symptomatic partial ornithine transcarbamylase deficiency. Rowe PC; Newman SL; Brusilow SW N Engl J Med; 1986 Feb; 314(9):541-7. PubMed ID: 3945292 [TBL] [Abstract][Full Text] [Related]
5. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. Oechsner M; Steen C; Stürenburg HJ; Kohlschütter A J Neurol Neurosurg Psychiatry; 1998 May; 64(5):680-2. PubMed ID: 9598692 [TBL] [Abstract][Full Text] [Related]
6. Partial ornithine transcarbamylase deficiency in females: diagnosis by an immunohistochemical method. Hayasaka K; Metoki K; Ishiguro S; Kato S; Chiba T; Hirooka M; Kikuchi M; Kurobane I; Narisawa K; Tada K Eur J Pediatr; 1987 Jul; 146(4):370-2. PubMed ID: 3308467 [TBL] [Abstract][Full Text] [Related]
7. Neurological features and computed tomography of the brain in children with ornithine carbamoyl transferase deficiency. Kendall BE; Kingsley DP; Leonard JV; Lingam S; Oberholzer VG J Neurol Neurosurg Psychiatry; 1983 Jan; 46(1):28-34. PubMed ID: 6842197 [TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of girls with ornithine transcarbamylase deficiency. Maestri NE; Brusilow SW; Clissold DB; Bassett SS N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603 [TBL] [Abstract][Full Text] [Related]
10. Partial ornithine transcarbamylase deficiency associated with recurrent hyperammonemia, lethargy and depressed sensorium. Oizumi J; Ng WG; Koch R; Shaw KN; Sweetman L; Velazquez A; Donnell GN Clin Genet; 1984 Jun; 25(6):538-42. PubMed ID: 6733950 [TBL] [Abstract][Full Text] [Related]
11. A female case of ornithine transcarbamylase deficiency with marked computed tomographic abnormalities of the brain. Takayanagi M; Ohtake A; Ogura N; Nakajima H; Hoshino M Brain Dev; 1984; 6(1):58-60. PubMed ID: 6731721 [TBL] [Abstract][Full Text] [Related]
12. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency. Batshaw ML; Msall M; Beaudet AL; Trojak J J Pediatr; 1986 Feb; 108(2):236-41. PubMed ID: 3944708 [TBL] [Abstract][Full Text] [Related]
13. Acute hemiparesis as the presenting sign in a heterozygote for ornithine transcarbamylase deficiency. de Grauw TJ; Smit LM; Brockstedt M; Meijer Y; vd Klei-von Moorsel J; Jakobs C Neuropediatrics; 1990 Aug; 21(3):133-5. PubMed ID: 2234317 [TBL] [Abstract][Full Text] [Related]
14. Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations. Gao J; Gao F; Hong F; Yu H; Jiang P Am J Emerg Med; 2015 Mar; 33(3):474.e1-3. PubMed ID: 25227973 [TBL] [Abstract][Full Text] [Related]
15. Intermittent hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency. Gulati S; Menon S; Kabra M; Kalra V Indian J Pediatr; 2004 Jul; 71(7):645-7. PubMed ID: 15280615 [TBL] [Abstract][Full Text] [Related]
16. Prenatal counseling in heterozygotes for ornithine transcarbamylase deficiency. Fries MH; Kuller JA; Jurecki E; Packman S Clin Pediatr (Phila); 1994 Sep; 33(9):525-9. PubMed ID: 8001320 [TBL] [Abstract][Full Text] [Related]